BioHealth News
Biotechnology Investment Incentive Tax Credit (BIITC) Program Now Accepting Applications for 2025
The Maryland Department of Commerce has officially opened the 2025 Biotechnology Investment Incentive Tax Credit (BIITC) program. Qualified Maryland Biotechnology Companies (QMBCs) can submit…
Read More
$50 Million ‘Build to Scale’ Funding Opportunity Aims to Boost Technology Entrepreneur Ecosystems
The U.S. Economic Development Administration (EDA) is accepting applications for its FY24 $50 million Build to Scale program to support organizations that strengthen entrepreneurial ecosystems to…
Read More
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
GAITHERSBURG, Md., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read More
Forbes: Where Are Federal Economic Development Investments Going?
Billions in funding from the CHIPS & Science Act, Bipartisan Infrastructure Law, Inflation Reduction Act, and American Rescue Plan–known as the Investing in America…
Read More
BioHealth Capital Region Announces Finalists for the 9th Annual Crab Trap Competition
The BioHealth Capital Region is proud to announce the finalists for this year’s Crab Trap Competition, selected from a highly competitive pool of a…
Read More
ARPA-H Launches PRECISE-AI to Ensure Long-Term Reliability of AI in Healthcare
ARPA-H has announced a new funding opportunity through its PRECISE-AI program, aimed at maintaining the accuracy and reliability of AI-enabled medical tools over time.…
Read More
REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect
ROCKVILLE, Md., Sept. 3, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive results from the Phase I/II/III CAMPSIITE® trial of RGX-121 for the treatment of patients with…
Read More
Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network
Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on Drug Abuse Clinical Trials…
Read More
BISNOW: Join the Leaders in Life Sciences and Real Estate at the International Life Sciences Real Estate Conference Next Week in Rockville
The International Life Sciences Real Estate Conference, taking place on September 11-12, 2024, at the Bethesda North Marriott Hotel & Conference Center in Rockville,…
Read More
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read More
BioHealth Capital Region Week is Just Two Weeks Away: Register Now!
As we approach the exciting BioHealth Capital Region Week, slated to kick off in just two weeks, there's still time to secure your spot…
Read More
Global Leadership in Clinical Research: A Conversation with Peter Ronco, CEO of Emmes
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., sits down with Peter Ronco, Chief Executive Officer of Emmes,…
Read More
FDA approves Novavax’s 2024-2025 COVID-19 Vaccine
GAITHERSBURG, Md., Aug. 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the Novavax COVID-19 Vaccine, Adjuvanted…
Read More
Activation Capital Selects 10 Startups for Inaugural Frontier BioHealth Program
RICHMOND, Va., Aug. 28, 2024 /PRNewswire/ -- Activation Capital, an innovation ecosystem development organization, has announced the selection of 10 fast-growing startups from across the country…
Read More
Arlington’s OxiWear Receives FDA Clearance as a Medical Device
ARLINGTON, Va., Aug. 28, 2024 /PRNewswire/ -- OxiWear, a pioneering company in wearable health technology, is proud to announce that it has received clearance from the…
Read More